Immune cells trained to kill HPV tumors show promise in early trial
NCT ID NCT02379520
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested a new treatment for people with HPV-related cancers that came back or didn't respond to standard care. Researchers took immune cells (T cells) from patients' blood, trained them to attack HPV-infected cancer cells, and gave them back. The goal was to find a safe dose and see if the cells could shrink tumors. Some patients also received the drug nivolumab to boost the immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.